GlassScriptPhysician profile
Brian J Cady
NPI 1811908775
$412.17
in general payments reported to CMS, 2019-2025
13 companies · $29.61 in 2025
The $29.61 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.25 · 2021: $37.74 · 2022: $50.61 · 2023: $105 · 2024: $144 · 2025: $29.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $278.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $63.84 | 2021-2023 | Trulance, Xifaxan |
| Almatica Pharma LLC | $52.27 | 2024-2025 | Loreev Xr |
| Dexcom, INC. | $46.64 | 2024 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $36.46 | 2019-2024 | Fasenra |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $35.54 | 2023-2024 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $34.16 | 2022-2023 | Rexulti |
| Lundbeck LLC | $33.82 | 2023 | Rexulti |
| Abbvie INC. | $21.35 | 2021 | |
| Novartis Pharmaceuticals Corporation | $20.43 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.79 | 2022 | |
| Exact Sciences Corporation | $18.97 | 2024 | Cologuard Collection Kit |
| Pfizer INC. | $15.45 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $13.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Cady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.